Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

IMMUNEEL THERAPEUTICS PRIVATE LIMITED

Active

IMMUNEEL THERAPEUTICS PRIVATE LIMITED having CIN U24230KA2018PTC119691 is 6 years , 6 month old Private Indian Company incorporated on 20 Dec 2018. It is classified as Non-government company and is registered at ROC Bangalore. Its authorized share capital is Rs. 1,000,000,000 and its paid up capital is Rs. 463,660. It's NIC code is 24230 (which is part of its CIN).

As per the NIC code, it is involved in . IMMUNEEL THERAPEUTICS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2024. Directors of IMMUNEEL THERAPEUTICS are Amit Mookim and Arun Anand.

IMMUNEEL THERAPEUTICS ' Corporate Identification Number (CIN) is U24230KA2018PTC119691 and its registration number is 119691. Users may contact IMMUNEEL THERAPEUTICS on its Email address - compliance@immuneel.com Registered address of IMMUNEEL THERAPEUTICS is 29/P2, 8TH FLOOR, NARAYANA HEALTH CITY HOSUR ROAD, BOMMASANDRA INDUSTRIAL AREA,,BENGALURU,Karnataka,India-560099. Current status of IMMUNEEL THERAPEUTICS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
1,000,000,000

as on 20/06/2025

Paid Up Capital
463,660

as on 20/06/2025

Company Age
6 Year, 6 Months
Last Filing with ROC
0 Year, 8 Months

Company Information

CIN U24230KA2018PTC119691
Company Status Active
Registration Number 119691
Date of Incorporation 12/20/2018
RoC ROC Bangalore
Company Age 6 years & 184 days
Authorized Capital ₹ 1000000000
Paid-up capital ₹ 463660
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID compliance@immuneel.com
Address 29/P2, 8th Floor, Narayana Health City, Hosur Road, Bommasandra Industrial Area BENGALURU Karnataka India 560099
Website immuneel.com
Contact Number +91*******

Location on Map

Director

DIN Name Date OF Appointment Designation Tenure
00863123 24 Jul 2023 Director 6 years
00347229 14 Mar 2023 Director 6 years
05268309 14 Mar 2023 Director 6 years
09543486 28 Jul 2023 Director 6 years
09548701 20 Apr 2022 Director 6 years
07627928 29 Oct 2024 Director 6 years
10754604 19 Sep 2024 Director 6 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
Active
6,76,57,32,317.00 1 Maharashtra
Active
2,94,76,79,300.00 1 Maharashtra
Active
0.00 1 -
Active
2,31,18,73,020.00 2 Karnataka
Active
1,25,00,000.00 2 Karnataka
Active
1,52,06,22,220.00 2 Karnataka
Strike Off
1,00,000.00 2 Karnataka
Active
79,13,74,110.00 2 Karnataka
Active
16,28,88,36,100.00 2 Maharashtra
Active
35,54,87,461.00 1 Maharashtra
Amalgamated
5,00,000.00 2 Karnataka
Active
1,00,000.00 2 Delhi
Active
0.00 2 Karnataka
Active
9,62,26,278.00 2 Maharashtra
Active
34,49,540.00 2 Maharashtra
Active
4,79,50,000.00 2 Maharashtra
Active
4,76,54,000.00 2 Odisha (Orissa)
Active
20,77,10,66,570.00 2 Karnataka
Active
1,00,000.00 2 Karnataka
Active
3,88,580.00 2 Haryana
Active
71,86,98,920.00 2 Karnataka
Active
1,26,736.00 2 Karnataka
Active
5,65,020.00 2 Karnataka

Charges on assets

No Data Available
Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Not Available

Registered Details

CIN
U24230KA2018PTC119691
Incorporation
6 years , 6 month
Company Email
compliance@immuneel.com
Paid up Capital
₹ 463,660
Authorised Capital
₹ 1,000,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 0.00%
₹ 0
EBITDA arrow 0.00%
₹ 0
Net Profit arrow0.00%
₹ 0
Networth arrow0.00%
₹ 0
Borrowings arrow0.00%
₹ 0
Assets arrow0.00%
₹ 0
Gross Margin arrow0.00%
₹ 0
Operating Margin arrow0.00%
₹ 0
Net Profit Margin arrow0.00%
₹ 0
Return on Equity arrow0.00%
₹ 0
ROCE arrow9.29%
₹ 140,987.4
Debt to Equity arrow0.00%
₹ 0

Financial Highlights

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capital
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency 0.00 0.00 0.00 0.00 0.00
Total Debt/Equity 0.00 0.00 0.00 0.00 0.00
Total Debt/Assets 0.00 0.00 0.00 0.00 0.00
Total Assets/Equity 0.00 0.00 0.00 0.00 0.00
Liquidity 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.00 0.00 0.00 0.00 0.00
Quick Ratio 0.00 0.00 0.00 0.00 0.00
Interest Coverage 0.00 0.00 0.00 0.00 0.00
Performance 0.00 0.00 0.00 0.00 0.00
Gross Margin 0.00 0.00 0.00 0.00 0.00
Operating Margin 0.00 0.00 0.00 0.00 0.00
Net Margin 0.00 0.00 0.00 0.00 0.00
Return 0.00 0.00 0.00 0.00 0.00
Return on Equity 0.00 0.00 0.00 0.00 0.00
Pre-tax ROCE 0.00 0.00 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00 0.00 0.00
Pre-tax ROIC 0.00 0.00 0.00 0.00 0.00
Efficiency 0.00 0.00 0.00 0.00 0.00
Days Payable 0.00 0.00 0.00 0.00 0.00
Days Inventory 0.00 0.00 0.00 0.00 0.00
Days Receivable 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00
Total Asset Turnover 0.00 0.00 0.00 0.00 0.00
Working Capital 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00
Working Capital Days 0.00 0.00 0.00 0.00 0.00
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Immuneel Therapeutics Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Immuneel Therapeutics Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Immuneel Therapeutics Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Immuneel Therapeutics Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number Registration Number Address

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Immuneel Therapeutics Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Immuneel Therapeutics Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Immuneel Therapeutics Private Limited

What is IMMUNEEL THERAPEUTICS PRIVATE LIMITED ?

IMMUNEEL THERAPEUTICS PRIVATE LIMITED having CIN U24230KA2018PTC119691 is 6 years , 6 month old Private Indian Company incorporated with MCA on 19 Sep 2024. IMMUNEEL THERAPEUTICS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Bangalore with an Authorized Share Capital of 1,000,000,000 and paid-up capital is 463,660.

What is the CIN of IMMUNEEL THERAPEUTICS PRIVATE LIMITED?

CIN of IMMUNEEL THERAPEUTICS PRIVATE LIMITED is U24230KA2018PTC119691.

Where is IMMUNEEL THERAPEUTICS PRIVATE LIMITED located?

Address of IMMUNEEL THERAPEUTICS PRIVATE LIMITED is 29/p2, 8th floor, narayana health city hosur road, bommasandra industrial area,,bengaluru,karnataka,india-560099,.

Who are the directors of IMMUNEEL THERAPEUTICS PRIVATE LIMITED ?

The company has 12 directors/key management personnel Ranjan Pai,. .,kiran Shaw,prem Pavoor,arun Anand,siddhartha Mukherjee,prem Pavoor,kiran Shaw,amit Mookim,saif Khalfan Al Hasani,ranjan Pai,arun Anand,

What is the contact details of IMMUNEEL THERAPEUTICS PRIVATE LIMITED ?

Email : compliance@immuneel.com
Address : 29/P2, 8th Floor, Narayana Health City, Hosur Road, Bommasandra Industrial Area BENGALURU Karnataka India 560099

What does IMMUNEEL THERAPEUTICS PRIVATE LIMITED do?

IMMUNEEL THERAPEUTICS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Search

Top Companies in your State

Enquiry